Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

54 trials with published results (9%)

Research Maturity

350 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.9%

30 terminated out of 617 trials

Success Rate

92.1%

+5.6% vs benchmark

Late-Stage Pipeline

21%

127 trials in Phase 3/4

Results Transparency

15%

54 of 350 completed with results

Key Signals

54 with results92% success30 terminated

Data Visualizations

Phase Distribution

470Total
Not Applicable (259)
Early P 1 (22)
P 1 (27)
P 2 (35)
P 3 (43)
P 4 (84)

Trial Status

Completed350
Unknown145
Recruiting47
Terminated30
Withdrawn17
Not Yet Recruiting15

Trial Success Rate

92.1%

Benchmark: 86.5%

Based on 350 completed trials

Clinical Trials (617)

Showing 20 of 20 trials
NCT06206746Not ApplicableRecruitingPrimary

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

NCT06882291Not ApplicableCompletedPrimary

Intermittent Fasting Diet Versus Resistive Exercise Program on Insulin Resistance in Obese Women With P.C.O.S

NCT05950282Recruiting

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

NCT07385716Not ApplicableCompletedPrimary

Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome

NCT03049462Phase 1RecruitingPrimary

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

NCT03059173Phase 3RecruitingPrimary

Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome

NCT03625531Phase 3CompletedPrimary

A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS

NCT05966792Not ApplicableCompletedPrimary

SGLT2 Inhibitors in Treating Patients With PCOS

NCT04407754Not ApplicableRecruitingPrimary

Myo-Inositol for Infertility in PCOS

NCT06222437Phase 1WithdrawnPrimary

Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy

NCT07483723Not ApplicableRecruitingPrimary

Glucose Profiles in Women With Polycystic Ovary Syndrome

NCT07465575Not ApplicableNot Yet RecruitingPrimary

Berberine Phytosome for Signs and Symptoms of Polycystic Ovary Syndrome (PCOS)

NCT06551285Not ApplicableRecruitingPrimary

Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.

NCT06047574RecruitingPrimary

Multidisciplinary Diagnosis and Treatment of Polycystic Ovary Syndrome

NCT07446985Not ApplicableRecruitingPrimary

Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma?

NCT07441811CompletedPrimary

Urine Albumin/Creatinine Ratio and Renal Function Differences in Phenotypes of Polycystic Ovary Syndrome.

NCT05279768Phase 1CompletedPrimary

Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.

NCT03905941Early Phase 1WithdrawnPrimary

Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age

NCT07402980CompletedPrimary

Development of the Polycystic Ovary Syndrome Symptoms Inventory

NCT06852365Phase 2Recruiting

Combined Oral Contraceptive Pill and Resistance Starch

Scroll to load more

Research Network

Activity Timeline